Modus Therapeutics Holding AB
556851-9523ActiveSwedish biotech developing sevuparin for severe inflammatory conditions.
Översikt
- 1–4
- Anställda
- 500–749t SEK
- Omsättning
- 2011
- Grundat
Nyckelbeslutsfattare
John Öhd
Chief Executive Officer
Johan Dighed
Board member
Viktor Drvota
Chairman
Michael Forer
Member of the Nomination Committee
+3 fler kontakter i Funnelfeedr
Beskrivning
Modus Therapeutics is a Swedish biotechnology company focused on developing novel treatments for severe medical conditions. Their primary focus is the development of their proprietary polysaccharide, sevuparin. Sevuparin is being investigated as a potential therapeutic agent for several high unmet m...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Konsultverksamhet avseende företags organisation
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556851952301
Beslutsfattare
7 kontakter i FunnelfeedrJohn Öhd
Chief Executive Officer
Johan Dighed
Board member
Viktor Drvota
Chairman
Michael Forer
Member of the Nomination Committee
Ellen Donnelly
Board Member
Claes Lindblad
CFO & Head of IR
Ellen K. Donnelly
Board Member
Liknande företag
20 liknande företag i FunnelfeedrSangair AB
5–9 anställdaDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Aptahem AB
1–4 anställdaBiotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Kyowa Kirin International NewCo Sweden AB
Global specialty pharmaceutical company focused on innovative drug development.
ZEALAND PHARMA A/S
0 anställdaDeveloping peptide medicines for metabolic health challenges globally.
Disruptive Pharma AB (publ)
5–9 anställdaSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
Utforska mer
Frågor om Modus Therapeutics Holding AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo